
Pharvaris BV raises $66m to advance oral HAE drug
The Series B financing was led by Foresite Capital. New investors Bain Capital Life Sciences, venBio and Venrock, as well as the investors of a €15m...

Qiagen/Illumina: Earthquake in NGS IVD market
The announcement of the 15-year partnership of next generation sequencing (NGS) market leader Illumina and QIAGEN came after Illumina cut its 2019...

Cell transdifferentiation specialist Mogrify Ltd raises US$16m
The company has developed a unique scalable technology for direct cellular transdifferentiation, based on the FANTOM5 dataset of human regulatory...

Abcam buys Expedeon’s immunology business
“This purchase price is equivalent to twice Expedeon’s current market capitalisation or excess of 9-times 2018 annual group revenue,” the company...

Rotavirus vaccines kill cancer cells
The team headed by Aurelian Marabelle discovered in mice that commercially available vaccines against rotavirus – which causes diarrhea in children...

Healx Ltd raises $56m in Series B financing
The financing was led by Atomico and joined by Intel Capital, Global Brain and btov Partners as new investors. Existing investors from a US$10m...

Polyphor presents AMR breaker
In Nature, Anatol Luther et al. from Polyphor AG and the University of Zurich describe the discovery and characterisation of a new class of...